MINGCHEN HEALTH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.09 CNY | +2.34% |
|
-3.65% | -21.65% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,626 | 1,853 | 4,641 | 4,811 | 6,084 | 5,683 |
| Enterprise Value (EV) 1 | 1,222 | 1,429 | 4,367 | 4,572 | 6,035 | 5,568 |
| P/E ratio | 55.5 x | 79.8 x | 45.2 x | 36.1 x | 238 x | 80.1 x |
| Yield | 0.5% | 0.66% | 0.67% | 0.76% | - | - |
| Capitalization / Revenue | 2.98 x | 3.58 x | 6.82 x | 6.47 x | 6.43 x | 3.47 x |
| EV / Revenue | 2.24 x | 2.76 x | 6.42 x | 6.14 x | 6.38 x | 3.4 x |
| EV / EBITDA | 41 x | 54.6 x | 40.9 x | 38.2 x | 358 x | 22.6 x |
| EV / FCF | -70.4 x | 77.7 x | -81.9 x | 198 x | 222 x | 116 x |
| FCF Yield | -1.42% | 1.29% | -1.22% | 0.51% | 0.45% | 0.86% |
| Price to Book | 2.95 x | 3.28 x | 7.08 x | 6.35 x | 8.23 x | 6.84 x |
| Nbr of stocks (in thousands) | 222,287 | 222,287 | 222,287 | 222,287 | 221,780 | 221,663 |
| Reference price 2 | 7.315 | 8.335 | 20.88 | 21.64 | 27.43 | 25.64 |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/28/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 546.3 | 517.5 | 680.6 | 744.1 | 945.4 | 1,638 |
| EBITDA 1 | 29.77 | 26.15 | 106.7 | 119.5 | 16.86 | 246.8 |
| EBIT 1 | 21.13 | 16.8 | 94.31 | 101.7 | -20.06 | 101.5 |
| Operating Margin | 3.87% | 3.25% | 13.86% | 13.66% | -2.12% | 6.2% |
| Earnings before Tax (EBT) 1 | 34.11 | 26.2 | 104.8 | 127.5 | 15.25 | 56.63 |
| Net income 1 | 29.66 | 23.08 | 102.2 | 133.5 | 25.33 | 70.36 |
| Net margin | 5.43% | 4.46% | 15.02% | 17.94% | 2.68% | 4.3% |
| EPS 2 | 0.1319 | 0.1044 | 0.4615 | 0.5989 | 0.1154 | 0.3200 |
| Free Cash Flow 1 | -17.36 | 18.38 | -53.29 | 23.14 | 27.24 | 48.06 |
| FCF margin | -3.18% | 3.55% | -7.83% | 3.11% | 2.88% | 2.93% |
| FCF Conversion (EBITDA) | - | 70.29% | - | 19.36% | 161.54% | 19.48% |
| FCF Conversion (Net income) | - | 79.65% | - | 17.34% | 107.54% | 68.3% |
| Dividend per Share 2 | 0.0366 | 0.0549 | 0.1401 | 0.1648 | - | - |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/28/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 404 | 424 | 275 | 238 | 48.1 | 116 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -17.4 | 18.4 | -53.3 | 23.1 | 27.2 | 48.1 |
| ROE (net income / shareholders' equity) | 5.45% | 4.13% | 16.7% | 18.9% | 3.38% | 9.08% |
| ROA (Net income/ Total Assets) | 1.91% | 1.5% | 7.47% | 6.87% | -1.13% | 5.04% |
| Assets 1 | 1,553 | 1,536 | 1,369 | 1,942 | -2,236 | 1,396 |
| Book Value Per Share 2 | 2.480 | 2.540 | 2.950 | 3.410 | 3.330 | 3.750 |
| Cash Flow per Share 2 | 0.5900 | 1.450 | 0.8900 | 1.130 | 0.6100 | 0.7800 |
| Capex 1 | 12.6 | 17.5 | 13.9 | 15.5 | 151 | 12.7 |
| Capex / Sales | 2.3% | 3.37% | 2.05% | 2.08% | 15.92% | 0.78% |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/28/22 | 4/26/23 | 4/28/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.65% | 602M | |
| +13.12% | 391B | |
| +12.87% | 136B | |
| +18.64% | 77.5B | |
| -11.79% | 66.4B | |
| -8.34% | 48.3B | |
| -4.18% | 38.99B | |
| +6.89% | 35.51B | |
| +12.00% | 18.18B | |
| +15.53% | 16.39B |
- Stock Market
- Equities
- 002919 Stock
- Financials Mingchen Health Co.,Ltd.